These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1661 related items for PubMed ID: 33648424

  • 1. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X, Xu X, He XF, Yuan Y, Chen C, Shen XY, Su S, Chen Z, Xu ST, Huang YH.
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 3. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X, Ren H, Zhang Y, Wang B, Ma H.
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [Abstract] [Full Text] [Related]

  • 4. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ, Ren XN, Xu XJ, Ruan XX, Wang YL, Yao TT.
    Technol Cancer Res Treat; 2020 Dec; 19():1533033820957023. PubMed ID: 32910747
    [Abstract] [Full Text] [Related]

  • 5. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
    Hu Y, Zhang Y, Ding M, Xu R.
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
    [Abstract] [Full Text] [Related]

  • 7. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H, Zhang L, Ding X, Sui X.
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W, Xia Y, Bi Y, Wen F, Hu D, Luo L.
    Aging (Albany NY); 2019 Mar 11; 11(5):1427-1439. PubMed ID: 30860979
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
    Chen Y, Liao W, Yuan A, Xu H, Yuan R, Cao J.
    Panminerva Med; 2022 Sep 11; 64(3):374-383. PubMed ID: 32506887
    [Abstract] [Full Text] [Related]

  • 18. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z, Mu T, Zhao L, Li Y, Zhu D, Pan Y.
    Bioengineered; 2022 Jan 11; 13(1):83-95. PubMed ID: 34951340
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang Z, Luo F, Xu J, Zhou Q, Dai F.
    J Cell Biochem; 2019 Jun 11; 120(6):9656-9666. PubMed ID: 30548308
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.